Transfection Reagents and Equipment Market Size Share and Industry Outlook to 2028

SKU: DMMD2031 | Last Updated On: Jan 07 2022 | No. of Pages: 180 | Available Formats

> Global Transfection Reagents and Equipment Market Expected to reach a high CAGR of 7.5% By 2028: DataM Intelligence

Global Transfection Reagents and Equipment Market is segmented By Product Type (Reagents (Lipid Mediated Transfection, DEAE-Dextran, Calcium Phosphate, Activated Dendrimers, Cationic Polymers, Others)), Equipment (Liposomes, Electroporation, Microinjection, Laserfection, Others), By Application (Biomedical Research (Cancer Research, Gene Expression, Transgenic Models) Protein Production, Therapeutic Delivery) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

The Global "Transfection Reagents and Equipment Market" is expected to grow at a CAGR of 7.5% during the forecast period (2021-2028).

Transfection is a process that involves the production of genetically modified cells with the utilization of foreign nucleic acid (DNA and RNA). Transfection is essential equipment used in the investigation studies for gene function and the modulation of gene expression.

Source: DataM Intelligence Analysis (2019)

Market Dynamics

The global transfection reagents and equipment market is driven by the rising incidence of infectious diseases, increase in the R&D expenditure and research activities by the pharmaceutical and biotechnology companies, technological advancements in transfection, increasing incidence of cancer, and the presence of various government initiatives.

Infectious diseases represent a significant health problem worldwide, both in terms of morbidity and mortality. A complex combination of environmental, pathogen, and host genetic factors plays a role in determining both susceptibility to microbes and the course of infection. According to CDC, in 2017, the number of visits to physician offices with infectious and parasitic diseases as the primary diagnosis are 15.5 million, and the number of emergency department visits with the infectious and parasitic infections as the primary diagnosis were 3.7 million. Also, the number of emergency department visits resulting in hospital admission with a principal hospital discharge diagnosis of infectious and parasitic diseases were 280,000. Thus, the rising incidence of infectious diseases is driving the market.

Further, in recent times, the biopharmaceutical industry has seen a significant patent cliff as several blockbuster biologics are facing patent expiration. Consequently, several companies have begun investing in the production of biosimilar alternatives to the off-patent biologics to overcome the threat of revenue loss. Hence, the patent cliff threat has significantly benefitted the market by spurring the adoption rate of transfection technology.

The presence of technological advancements in transfection are expected to boost the market. For instance, some of the advancements include CRISPR-CAS9, CAR-T, and Three Dimension (3D) Transfection Technology. Also, in August 2019, researchers of the Salk Institute have developed a new tool, named, dubbed SATI to edit the mouse genome, enabling the team to target a broad range of mutations and cell types. The new genome-editing technology could be expanded for use in a broad range of gene mutation conditions such as Huntington's disease and the rare premature aging syndrome. Further, according to a study published in July 2019, the researchers of Tufts University and the Chinese Academy of Sciences, have used lipid nanoparticles to deliver CRISPR/Cas9 gene-editing tools for the potential treatment of hyperlipidemia. Furthermore, the Life Technologies has launched the Lipofectamine, lipid-based formulations for nucleic acid delivery, which enhances the cell viability and reproducibility during transfection process of hard to transfect cell lines by optimization in different steps of transfection.

Rising incidence of cancer is one of the dominating factors, propelling the global transfection reagents and equipment market. For instance, According to WHO, cancer is the second leading cause of death worldwide, and is responsible for around 9.6 million deaths in 2018 and globally, about 1 in 6 deaths is only because of cancer. The International Agency for Research on Cancer has reported that there will be 413,000 new cases in the forecast period. Thus, the rising incidences of cancer are driving the market.

However, the high cost of transfection reagents and equipment, risk factors during insertion of the reagents, selective effectiveness and certain limitations of transfection reagents and cytotoxic effect associated with transfection technology are the major factors restraining the transfection reagents and equipment market.

The number of cells that can be effectively transfected by the methods, and the limited clinical and laboratory use, owing to the integration of viral vectors randomly into the genome producing significant bio-hazardous risks are some of the limitations offered by the transfection reagents.

Market Segmentation

The reagents segment is sub-segmented into lipid-mediated transfection, DEAE-dextran, activated dendrimers, calcium phosphate, cationic polymers, and others. The reagents segment is expected to dominate the market over the forecast period. This is owing to the increasing commercial adoption rates of these reagents. For instance, OZ Biosciences revolutionized the Polyfection with the design of Helix-IN, a novel patented Cationic Hydroxylated Amphiphilic Multi-block Polymer (CHAMP Technology). This novel bi-functional co-polymer is biocompatible, ionizable, pH-responsive, and biodegradable. Thus, the increased adoption of reagents owing to the presence of products are driving the market.

Transfection equipment can be sub-segmented into liposomes, electroporation, microinjection, laserfection, and others. Rapidly growing volume of genomics-based research and development initiatives and the introduction of user-friendly products like portable DNA sequencers are expected to propel the transfection reagent and equipment market during the forecast period. Owing to the presence of expensive laser-based equipment used for the different transfection methods like laserfection or optoinjection are estimated to drive the growth of the equipment segment.

Electroporation segment is expected to boost the market over the forecast period. Extensive portfolios for a range of electroporation products offered by the major and the emerging players are stimulating the growth of the segment. Moreover, several advantages provided by the method like the ease of use, variability, and timeliness are escalating the growth of the segment. For instance, on November 09, 2018 CRISPR Therapeutics and MaxCyte announced the expansion of the existing relationship by entering into a non-exclusive commercial license agreement which allows the CRISPR Therapeutics to deploy the MaxCyte’s Flow Electroporation® Technology to develop CRISPR/Cas9-based therapies in immuno-oncology. Thus, the presence of extensive product portfolios and the added advantages of the electroporation are driving the market.

Source: DataM Intelligence Analysis (2019)

By application, the transfection reagents and equipment market can be segmented into biomedical research, protein production, and therapeutic delivery. Biomedical research is further sub-segmented into gene expression studies, cancer research, and transgenic models.

Biomedical research is expected to boost the market over the forecast period, owing to the increased adoption of reagents for biomedical research. For instance, AltoFect of Altogen biosystems transfection reagent enables the researchers to overcome the challenges and limitations related to primary cells and difficult-to-transfect cell lines. Also, Gene expression studies were expected to be the most prominent application. The expansion of the genomic data pool and the growing emphasis on the translation of genomic information in the clinical workflow are leading to a considerable share of this segment. The presence of a substantial number of ongoing research projects that aim at the in-depth investigation of key mechanisms, which underlie chromosomal anomalies, is also supplementing the growth of the segment.

Therapeutic delivery is expected to boost the market over the forecast period, owing to the increased adoption of reagents for therapeutic delivery. In May 2019, Altogen Biosystems announced the launch of real-time adaptive cGMP manufacturing of liver-targeted in vivo transfection reagent. This new product enables dose, formulation, and product changes within a clinical protocol in response to the emerging clinical data as well as targeted delivery to hepatocellular carcinoma cells and increased in vivo stability of cargo therapeutics. This novel liver-targeted delivery system may enable groundbreaking transfection efficiency medical applications, including gene and oligonucleotides therapy of liver cancers. Thus, the growing adoption of transfection reagents for therapeutic delivery is driving the market.

Geographical Analysis

North America is dominating the global transfection reagents and equipment market in 2018 and is estimated to hold significant market size over the forecast period (2020-2027) owing to the rising incidence of various cancers, the increasing demand for proteomics and genomics technology, and the upfront initiatives taken by the government related to preventive healthcare.

The rising incidence of cancer is expected to boost the market. For instance, according to the National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the US, and 609,640 people died from the disease. Thus, the growing number of cancer cases is driving the market.

The presence of upfront initiatives taken by the government related to preventive healthcare is expected to boost the market. For instance, the American cancer society has invested more than $4.8 billion in cancer research, to find more and better treatments, uncover factors that may cause cancer, and improve cancer patients' quality of life. Also, the National Cancer Institute coordinated the National Cancer Program, which conducts and supports the research, health information dissemination, and other programs related to the prevention, cause, diagnosis, and the treatment of cancer, rehabilitation from cancer, and continuous care of cancer patients. Thus, the presence of government initiatives for preventive healthcare is driving the market.

Funding and federal agencies, like the National Science Foundation (NSF), are offering the biotechnology sector with huge funding to carry out the biotechnology-based investigational studies. Moreover, international funding bodies like NIH and Welcome Trust are expected to play a vital role in the market growth by giving the funds for genetic research studies.

Source: DataM Intelligence Analysis (2019)

Competitive Landscape

The key players operating in the global transfection reagents and equipment market are Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Illumina, Inc., Norgen Biotek Corp., QIAGEN, PerkinElmer Inc., OriGene Technologies Inc., Promega Corporation, and Thermo Fisher Scientific Inc.

The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the transfection reagents and equipment market globally. For instance,

On December 13, 2018, Polyplus-transfection SA, announced the launch of PEIpro-GMP, a transfection reagent designed for the clinical and the commercial lentivirus and adeno-associated virus (AAV) production of cell & gene therapies.

On May 22, 2018, Altogen Biosystems announced the launch of AltoFect, the second-generation transfection reagent for primary cell types and hard-to-transfect cell lines.

In 2016, FormuMax Scientific, Inc., has launched the Trans-HiTM, as a superior transfection reagent to compete against the leading products in the market. Trans-HiTM is created based on proprietary polymer technology. It forms stable complex particles with DNA and rapidly releases the DNA molecules upon endocytosis into the cytoplasm. 

Why Purchase the Report?

  • Visualize the composition of the global transfection reagents and equipment market in terms of various product types, applications, and end-user highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the global transfection reagents and equipment market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the global transfection reagents and equipment market-level 4/5 segmentation.
  • A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players.

The Global Transfection Reagents and Equipment market report would provide access to an approx., 70 market data tables, 62 figures, and 180 pages

Target Audience

Trending Topics

Transfection Reagents and Equipment Market

Transfusion Diagnostics Market

 

Table of Contents

  1. Transfection Reagents and Equipment Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Transfection Reagents and Equipment Market – Market Definition and Overview

  3. Transfection Reagents and Equipment Market – Executive Summary

    1. Market Snippet by Product type
    2. Market Snippet by Application
    3. Market Snippet by End-user
  4. Transfection Reagents and Equipment Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. The increasing incidences of cancer
        2. The presence of technological advancements in transfection
      2. Restraints
        1. The limitations of transfection reagents
      3. Opportunity
      4. Impact Analysis
  5. Transfection Reagents and Equipment Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Regulatory Analysis
    3. Supply Chain Analysis
    4. Pricing Analysis
    5. Unmet Needs
  6. Transfection Reagents and Equipment Market – By Product type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      2. Market Attractiveness Index, By Product Type Segment
    2. Reagents*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
        1. Lipid mediated transfection
        2. DEAE-dextran
        3. Calcium phosphate
        4. Activated dendrimers
        5. Cationic polymers
        6. Others
    3. Equipment
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
        1. Liposomes
        2. Electroporation
        3. Microinjection
        4. Laserfection
        5. Others
  7. Transfection Reagents and Equipment Market – By Application

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      2. Market Attractiveness Index, By Application Segment
    2. Biomedical research*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
      3. Cancer research
      4. Gene expression
      5. Transgenic models
    3. Protein production
    4. Therapeutic delivery
  8. Transfection Reagents and Equipment Market – By End-user

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
      2. Market Attractiveness Index, By End-user Segment
    2. Pharmaceutical and biotechnology companies *
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    3. Research institutes
    4. Others
  9. Transfection Reagents and Equipment Market - By Region

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. The U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. The U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  10. Transfection Reagents and Equipment Market Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Transfection Reagents and Equipment Market Company Profiles

    1. Bio-Rad Laboratories, Inc.*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Merck KGaA
    3. Agilent Technologies
    4. Illumina, Inc.
    5. Norgen Biotek Corp.
    6. QIAGEN
    7. PerkinElmer Inc.
    8. OriGene Technologies Inc.
    9. Promega Corporation
    10. Thermo Fisher Scientific Inc. (LIST NOT EXHAUSTIVE)
  12. Transfection Reagents and Equipment Market – Premium Insights

  13. Transfection Reagents and Equipment Market – Data M

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

LIST OF TABLES 

TABLE 01 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT TYPE, 2018, 2022 & 2028 ($ MILLION) 
TABLE 02 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2018, 2022 & 2028 ($ MILLION) 
TABLE 03 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2018, 2022 & 2028 ($ MILLION) 
TABLE 04 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY REGION, 2018, 2022 & 2028 ($ MILLION) 
TABLE 05 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2018, 2022 & 2028 ($ MILLION) 
TABLE 06 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT TYPE, 2018, 2022 & 2028 ($ MILLION) 
TABLE 07 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT TYPE, 2017-2028 ($ MILLION) 
TABLE 08 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2018, 2022 & 2028 ($ MILLION) 
TABLE 09 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION) 
TABLE 10 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2018, 2022 & 2028 ($ MILLION) 
TABLE 11 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION) 
TABLE 12 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY REGION, 2018, 2022 & 2028 ($ MILLION) 
TABLE 13 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY REGION, 2017-2028 ($ MILLION) 
TABLE 14 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2018, 2022 & 2028 ($ MILLION) 
TABLE 15 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION) 
TABLE 16 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT TYPE, 2017-2028 ($ MILLION) 
TABLE 17 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION) 
TABLE 18 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION) 
TABLE 19 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY REGION, 2017-2028 ($ MILLION) 
TABLE 20 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION) 
TABLE 21 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT TYPE, 2017-2028 ($ MILLION) 
TABLE 22 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION) 
TABLE 23 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION) 
TABLE 24 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY REGION, 2017-2028 ($ MILLION) 
TABLE 25 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION) 
TABLE 26 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT TYPE, 2017-2028 ($ MILLION) 
TABLE 27 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION) 
TABLE 28 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION) 
TABLE 29 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY REGION, 2017-2028 ($ MILLION) 
TABLE 30 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION) 
TABLE 31 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT TYPE, 2017-2028 ($ MILLION) 
TABLE 32 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION) 
TABLE 33 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION) 
TABLE 34 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY REGION, 2017-2028 ($ MILLION) 
TABLE 35 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION) 
TABLE 36 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT TYPE, 2017-2028 ($ MILLION) 
TABLE 37 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2017-2028 ($ MILLION) 
TABLE 38 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2017-2028 ($ MILLION) 
TABLE 39 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY REGION, 2017-2028 ($ MILLION) 
TABLE 40 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2017-2028 ($ MILLION) 
TABLE 41 BIO-RAD LABORATORIES, INC.: OVERVIEW 
TABLE 42 BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO 
TABLE 43 BIO-RAD LABORATORIES, INC.: KEY DEVELOPMENTS 
TABLE 44 MERCK: OVERVIEW 
TABLE 45 MERCK: PRODUCT PORTFOLIO 
TABLE 46 MERCK: KEY DEVELOPMENTS 
TABLE 47 AGILENT TECHNOLOGIES: OVERVIEW 
TABLE 48 AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO 
TABLE 49 AGILENT TECHNOLOGIES: KEY DEVELOPMENTS 
TABLE 50 ILLUMINA, INC.: OVERVIEW 
TABLE 51 ILLUMINA, INC.: PRODUCT PORTFOLIO 
TABLE 52 ILLUMINA, INC.: KEY DEVELOPMENTS 
TABLE 53 NORGEN BIOTEK CORP.: OVERVIEW 
TABLE 54 NORGEN BIOTEK CORP.: PRODUCT PORTFOLIO 
TABLE 55 NORGEN BIOTEK CORP.: KEY DEVELOPMENTS 
TABLE 56 QIAGEN: OVERVIEW 
TABLE 57 QIAGEN: PRODUCT PORTFOLIO 
TABLE 58 QIAGEN: KEY DEVELOPMENTS 
TABLE 59 PERKINELMER INC.: OVERVIEW 
TABLE 60 PERKINELMER INC.: PRODUCT PORTFOLIO 
TABLE 61 PERKINELMER INC.: KEY DEVELOPMENTS 
TABLE 62 ORIGENE TECHNOLOGIES INC.: OVERVIEW 
TABLE 63 ORIGENE TECHNOLOGIES INC.: PRODUCT PORTFOLIO 
TABLE 64 ORIGENE TECHNOLOGIES INC.: KEY DEVELOPMENTS 
TABLE 65 PROMEGA CORPORATION: OVERVIEW 
TABLE 66 PROMEGA CORPORATION: PRODUCT PORTFOLIO 
TABLE 67 PROMEGA CORPORATION: KEY DEVELOPMENTS 
TABLE 68 THERMO FISHER SCIENTIFIC INC.: OVERVIEW 
TABLE 69 THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO 
TABLE 70 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS 


 LIST OF FIGURES  
FIGURE 01 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY PRODUCT TYPE, 2018 & 2028 (%)  
FIGURE 02 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)  
FIGURE 03 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY END-USER, 2018 & 2028 (%)  
FIGURE 04 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY REGION, 2018 & 2028 (%)  
FIGURE 05 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)  
FIGURE 06 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 07 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET Y-O-Y GROWTH, BY PRODUCT TYPE, 2018-2028 (%)  
FIGURE 08 REAGENTS: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 09 EQUIPMENT: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 10 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET Y-O-Y GROWTH, BY APPLICATION, 2018-2028 (%)  
FIGURE 11 GENE EXPRESSION: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 12 CANCER RESEARCH: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 13 BIOMEDICAL RESEARCH: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 14 PROTEIN PRODUCTION: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 15 THERAPEUTIC DELIVERY: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 16 OTHERS: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 17 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET Y-O-Y GROWTH, BY END-USER, 2018-2028 (%)  
FIGURE 18 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 19 RESEARCH INSTITUTES: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 20 OTHERS: GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 21 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET Y-O-Y GROWTH, BY REGION, 2018-2028 (%)  
FIGURE 22 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET Y-O-Y GROWTH, BY COUNTRY, 2018-2028 (%)  
FIGURE 23 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 24 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY PRODUCT TYPE, 2018 & 2028 (%)  
FIGURE 25 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)  
FIGURE 26 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY END-USER, 2018 & 2028 (%)  
FIGURE 27 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY REGION, 2018 & 2028 (%)  
FIGURE 28 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)  
FIGURE 29 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 30 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY PRODUCT TYPE, 2018 & 2028 (%)  
FIGURE 31 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)  
FIGURE 32 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY END-USER, 2018 & 2028 (%)  
FIGURE 33 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY REGION, 2018 & 2028 (%)  
FIGURE 34 SOUTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)  
FIGURE 35 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 36 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY PRODUCT TYPE, 2018 & 2028 (%)  
FIGURE 37 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)  
FIGURE 38 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY END-USER, 2018 & 2028 (%)  
FIGURE 39 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY REGION, 2018 & 2028 (%)  
FIGURE 40 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)  
FIGURE 41 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 42 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY PRODUCT TYPE, 2018 & 2028 (%)  
FIGURE 43 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)  
FIGURE 44 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY END-USER, 2018 & 2028 (%)  
FIGURE 45 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY REGION, 2018 & 2028 (%)  
FIGURE 46 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)  
FIGURE 47 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, 2017-2028 ($ MILLION)  
FIGURE 48 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY PRODUCT TYPE, 2018 & 2028 (%)  
FIGURE 49 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY APPLICATION, 2018 & 2028 (%)  
FIGURE 50 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY END-USER, 2018 & 2028 (%)  
FIGURE 51 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY REGION, 2018 & 2028 (%)  
FIGURE 52 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SHARE, BY COUNTRY, 2018 & 2028 (%)  
FIGURE 53 BIO-RAD LABORATORIES, INC.: FINANCIALS  
FIGURE 54 MERCK: FINANCIALS  
FIGURE 55 AGILENT TECHNOLOGIES: FINANCIALS  
FIGURE 56 ILLUMINA, INC.: FINANCIALS  
FIGURE 57 NORGEN BIOTEK CORP.: FINANCIALS  
FIGURE 58 QIAGEN: FINANCIALS  
FIGURE 59 PERKINELMER INC.: FINANCIALS  
FIGURE 60 ORIGENE TECHNOLOGIES INC.: FINANCIALS  
FIGURE 61 PROMEGA CORPORATION: FINANCIALS  
FIGURE 62 THERMO FISHER SCIENTIFIC INC.: FINANCIALS  

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest